Author = Abdelkrim Ouammou
Novel Styrylquinoline Derivatives as Potential Anticancer Agents, In-Silico studies by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulations

Volume 11, Issue 4, December 2023, Pages 953-967

Amina Goudzal; Abdellah El Aissouq; HADAJI El ghalia; el hamdani hicham; Cheddadi Oussama; Abdelkrim Ouammou; Mohammed Bouachrine

Novel Styrylquinoline Derivatives as Potential Anticancer Agents, In-Silico studies by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulations


Prediction of Novel TRPV1 Antagonist: A Combination of 3D-QSAR, Molecular Docking, MD Simulations and ADMET Prediction

Volume 11, Issue 2, June 2023, Pages 353-368

Toughzaoui Abdelilah; Chedadi Oussama; Abdellah El Aissouq; El Ouardi Youssef; Mohammed Bouachrine; Abdelkrim Ouammou

Prediction of Novel TRPV1 Antagonist: A Combination of 3D-QSAR, Molecular Docking, MD Simulations and ADMET Prediction


In Silico Prediction of Novel (TRIM24) Bromodomain Inhibitors: A Combination of 3D-QSAR, Molecular Docking, ADMET Prediction, and Molecular Dynamics Simulation

Volume 10, Issue 4, December 2022, Pages 519-535

Chedadi Oussama; EL Aissouq Abbdellah; El Ouardi Youssef; Mohammed Bouachrine; Abdelkrim Ouammou

In Silico Prediction of Novel (TRIM24) Bromodomain Inhibitors: A Combination of 3D-QSAR, Molecular Docking, ADMET Prediction, and Molecular Dynamics Simulation


Combined 3D-QSAR and Molecular Docking Analysis of Styrylquinoline Derivatives as Potent anti-cancer Agents

Volume 10, Issue 3, September 2022, Pages 345-362

Rania Kasmi; Mohammed Bouachrine; Abdelkrim Ouammou

Combined 3D-QSAR and Molecular Docking Analysis of Styrylquinoline Derivatives as Potent anti-cancer Agents